Document is current

Any future updates will be listed below

Extended neoadjuvant dostarlimab provides durable benefit in resectable dMMR solid tumours

Crossref DOI link: https://doi.org/10.1038/s41571-025-01027-9

Published Online: 2025-05-07

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark